EdgeTestMarket TodayOptions TodayIPO
Start free

NEPHROPLUSNephrocare Health Services Limited

Rs 607.4▲ +1.84%
Market closedEquity EOD 26 Oct
Compare
Range since listingThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.48.1% up the range
Rs 446Rs 782
NEPHROPLUS price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 26 Oct
IndicatorsVolume

Loading NEPHROPLUS price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 6,095 cr
Larger than 50% of 8 peers
sector middle Rs 4,560 cr
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
5.5x
Lower than 62% of 8 peers
sector middle 7.0x
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
13.7%
Lower than 86% of 7 peers
sector middle 19.2%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.07
Higher than 71% of 7 peers
sector middle 0.01
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.0%
Lower than 62% of 8 peers
sector middle 0.2%

Peers are the listed companies in the exchange's own industry group: Healthcare Service Provider. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 11 Aug 2026), sales was Rs 282 cr and profit was Rs 32.0 cr.

Nothing in the filings we hold crosses one of our rules yet. Each rule needs a few complete years of results, so recently listed companies often show nothing here.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 3 results, the share rose on 1 and fell on 2, and moved by 3% or more on 2.

Q3 FY26Q1 FY27

Q1 FY27: results filed 11 Aug 2026. The share went from its close on 10 Aug 2026 to its close on 12 Aug 2026 -2.66%.

Fundamentals
Trailing-twelve-month valuation, margins and growth from the company's own filings.

We do not have quarterly financials for NEPHROPLUS yet. Some companies, mainly insurers, file in a format we cannot read at the moment. Everything else on this page is current.

What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 1,471 Cr of assets. Its owners funded 76% of that and borrowings 5%.

What it owns
27%
12%
22%
17%
11%
Plant, property and projects402 Cr
Goodwill and intangibles120 Cr
Investments178 Cr
Inventory33 Cr
Owed by customers317 Cr
Cash and bank255 Cr
Everything else166 Cr
How that is paid for
76%
10%
Shareholders1,116 Cr
Borrowings80 Cr
Owed to suppliers143 Cr
Other liabilities132 Cr
Cash and equivalents
Rs 124 Cr
Net debt
Rs -215 Cr
more cash than debt
Current ratio
2.80x
short-term assets per rupee due soon
Book value / share
Rs 111
EV / EBITDA
23.4x

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs 233 Cr, spent Rs 119 Cr on plant and equipment, and cash fell by Rs 2 Cr over the year.

From running the business
+233 Cr
Spent on or received from investing
-410 Cr
From or to lenders and shareholders
+157 Cr
Net change in cash
-2 Cr

Full financial year to 2026-03-31, from the company's cash flow statement.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
3 quarters
RevenueRs 282 Cr
Net profitRs 32 Cr
Dec 253 quarters filedJun 26

Each bar is one quarter as filed with the exchange, newest on the right, so the seasonal shape of the business is visible rather than smoothed away. Hover any quarter for its full figures and the change against the same quarter a year earlier. Revenue and profit are drawn on separate scales because they differ by an order of magnitude; reading one against the other would be misleading.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 4
DatePartySideQtyPriceValue
2026-09-24POLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUNDBUY25,45,719705Rs 179.47 Cr
2026-09-24EDORAS INVESTMENT HOLDINGS PTE LTDSELL8,42,109705.03Rs 59.37 Cr
2026-09-24MANSI SHARE AND STOCK BROKING PRIVATE LIMITEDBUY8,23,311705.24Rs 58.06 Cr
2026-09-24MANSI SHARE AND STOCK BROKING PRIVATE LIMITEDSELL8,15,776710.45Rs 57.96 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 26 Oct
RSI (14) - momentum
32.4Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
46%Near average
today 46%20d avg 56.9%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-10.58%
vs 200-DMA
-1.26%
1-month
-18.13%
3-month
-9.76%
1-year
-
Realized vol (30d)
25.9%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on NEPHROPLUS?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.